A(9-26)INSL3 [439]
A(9-26)INSL3
| SMILES | CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)O |
| InChIKey | HHIHBEIJOBMKLZ-XYUOUADWSA-N |
| Sequence | YCCLSGCTQQDLLTLCPY |
| HELM | PEPTIDE1{Y.C.C.L.S.G.C.T.Q.Q.D.L.L.T.L.C.P.Y}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 31 |
| Hydrogen bond donors | 30 |
| Rotatable bonds | 61 |
| Log P | -7.663 |
| Molecular weight (Da) | 2022.9 |
| Stereochemistry info | partial |
No bioactivity data available.
A(9-26)INSL3
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0